Evolv Technologies Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share

Net Loss per Share

3 Months Ended

Mar. 31, 2024

Basic and diluted net loss per share attributable to common stockholders are calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2024		2023
Numerator:









Net loss attributable to common stockholders – basic and diluted	$	(11,644)	$	(28,609)

Denominator:












Weighted average common shares outstanding - basic and diluted	153,076,719		146,433,378
Net loss per share attributable to common stockholders – basic and diluted	$	(0.08)	$	(0.20)

The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:


	Three Months Ended March 31,
	2024	2023
Options issued and outstanding	22,522,005	23,136,658
Public Warrants to purchase common stock	14,324,893	14,324,994
Warrants to purchase common stock (Finback)	117,423	1,590,984
Unvested restricted stock units	16,460,035	12,395,533
Unvested performance stock units	—	414,500
Earn-out shares*	15,000,000	15,000,000
Contingently issuable common stock*	1,897,500	1,897,500
	70,321,856	68,760,169

*Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period